Translate
About
Bonus Biogroup (TA:BONS) — investor relations, events, news, and company updates on 6ix.
Latest News
Jul 14 2025
Bonus Biogroup Appoints Renowned Cell Therapy Leader, Professor Edwin M. Horwitz, MD, PhD, to its Advisory Board
Feb 20 2025
Bonus Biogroup Announces U.S. Food and Drug Administration (FDA) Clearance of an Investigational New Drug (IND) Application for MesenCure™ Phase III Clinical Study in Respiratory Distress
Financials
Revenue
ILA0
Market Cap
ILA464.83 M
EPS
-0.04